Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Capital Group Municipal Income ETF
CGMU
$6.58B
| $1.43M | ﹤0.01% |
54,112
+51,505
| +1,976% | +$1.37M |
|
3027
PUT
Clorox
CLX
$12.8B
| $1.43M | ﹤0.01% |
9,000
| – | – |
|
3028
Dimensional US Large Cap Value ETF
DFLV
$7.03B
| $1.43M | ﹤0.01% |
+56,199
| New | +$1.38M |
|
3029
Reynolds Consumer Products
REYN
$5.53B
| $1.43M | ﹤0.01% |
50,440
-24,838
| -33% | -$691K |
|
3030
Southern First Bancshares
SFST
$608M
| $1.43M | ﹤0.01% |
57,578
+3,577
| +7% | +$93.3K |
|
3031
Immunocore
IMCR
$1.76B
| $1.42M | ﹤0.01% |
23,736
+23,705
| +76,468% | +$1.35M |
|
3032
Meritage Homes
MTH
$4.76B
| $1.42M | ﹤0.01% |
19,982
+3,128
| +19% | +$196K |
|
3033
Lifecore Biomedical
LFCR
$179M
| $1.42M | ﹤0.01% |
147,001
-1,466
| -1% | -$8.95K |
|
3034
CALL
Valero Energy
VLO
$98.4B
| $1.42M | ﹤0.01% |
+12,100
| New | +$1.41M |
|
3035
Avantis International Small Cap Value ETF
AVDV
$20B
| $1.42M | ﹤0.01% |
24,639
+14,404
| +141% | +$843K |
|
3036
Murphy Oil
MUR
$4.96B
| $1.42M | ﹤0.01% |
37,013
+5,567
| +18% | +$206K |
|
3037
Star Bulk Carriers
SBLK
$3.24B
| $1.42M | ﹤0.01% |
80,028
+3,021
| +4% | +$58.1K |
|
3038
Winmark
WINA
$1.26B
| $1.42M | ﹤0.01% |
4,259
-749
| -15% | -$254K |
|
3039
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$249M
| $1.42M | ﹤0.01% |
74,568
-29,086
| -28% | -$539K |
|
|
COOP
3040
DELISTED
Mr. Cooper
COOP
| $1.41M | ﹤0.01% |
27,928
+3,405
| +14% | +$156K |
|
3041
Agios Pharmaceuticals
AGIO
$2B
| $1.41M | ﹤0.01% |
49,869
+4,946
| +11% | +$123K |
|
3042
NRC Health Common Stock
NRC
$469M
| $1.4M | ﹤0.01% |
32,252
-268
| -0.8% | -$11.8K |
|
|
BFS
3043
Saul Centers
BFS
$860M
| $1.4M | ﹤0.01% |
38,081
+2,485
| +7% | +$89.3K |
|
3044
Invesco Golden Dragon China ETF
PGJ
$93.8M
| $1.4M | ﹤0.01% |
52,561
+2,853
| +6% | +$76.7K |
|
|
FTCH
3045
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $1.4M | ﹤0.01% |
231,623
-9,907
| -4% | -$47.7K |
|
|
NXRT
3046
NexPoint Residential Trust
NXRT
$626M
| $1.4M | ﹤0.01% |
30,709
+5,954
| +24% | +$257K |
|
|
DFSV
3047
Dimensional US Small Cap Value ETF
DFSV
$8.48B
| $1.4M | ﹤0.01% |
54,335
-439,274
| -89% | -$10.7M |
|
3048
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $1.4M | ﹤0.01% |
48,325
+4,353
| +10% | +$126K |
|
3049
Fidelity MSCI Communication Services Index ETF
FCOM
$1.8B
| $1.39M | ﹤0.01% |
34,630
+22,740
| +191% | +$863K |
|
3050
Iridium Communications
IRDM
$5.32B
| $1.39M | ﹤0.01% |
22,404
+745
| +3% | +$46.1K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.